You are in Herbal Remedies for other Internal Diseases > Medical Diseases > Xihuang Wan
Manufacturer : Beijing Tongrentang Pharmaceutical Company
Packing : 30g box
Pharmaceutical Ingredients : Traditional Chinese Medicine
Product Category : Medical Diseases
6 box course
Chinese Pinyin Name : Xihuang Wan.
English Name : Xi Huang Pills.
Product Category : Medical Diseases.
Functions and Indications : For the effective treatment of cancer. To prevent the growth of various cancer cells, reduce the side effects of chemotherapy and radiation therapy, improve the function of bone marrow in the production of blood cells.
Clinical applications for Xihuang Wan :
- Xihuang Wan has been used in the treatment of breast cancer, cervical cancer, bladder cancer, liver cancer, lung cancer, esophagus cancer, stomach cancer, thyroid cancer, colon cancer, leukemia, etc.
- Used in the treatment of various suppurative and proliferative diseases, such as mammary gland hyperplasia, breast fibroma, lymphatitis, osteomyelitis, and sepsis, chronic appendicitis, acute or chronic mumps, erysipelas, herpes roster, pyoderma, lymphatic tuberculosis, etc.
Main Ingredients : Pin Yin : Niu Huang, She Xiang, Ru Xiang, Mo Yao. Pharmaceutical Latin : Calculus Bovis, Moschus, Olibanum, Myrrh.
Usage and Dosage : Take 3g with water each time, 2 times daily.
Note : Each 30g box is for 5 day dose. One month course of treatment is recommended for this product.
Packing : 30g box.
Storage : Keep sealed in a dry cool place.
Approval : Ministry of Health standards for Traditional Chinese Medicine prescription drugs preparations ninth book WS3-B-1734-94.
Approval Licence Number Zhunzi Z11020073.
Chinese Herbal Medicine
Leading Brand Chinese Herbal Medicine
Herbal Medicine Pharmacy
Traditional Chinese Medicine
Natural Health Supplements
Menu of Categories
View Mobile Friendly Page
Chinese Herbal Medicine
Introduction : Cancer is a leading cause of death and a major public health problem, with increasing incidence and mortality. Chemotherapy, radical surgery, radiotherapy, immune, and target therapies have attained a certain therapeutic effect;,,, however, it is not possible to completely control the disease in a number of patients with cancer. Complementary and alternative medicine (CAM) is another tumor treatment approach that has been adopted for the use by an increasing number of physicians and patients,,, and is efficacious in the treatment of disease, controlling tumor related-pain, improving patient quality of life (QOL), and as palliative care.,, Traditional Chinese medicine (TCM) is an important part of CAM and has been reported to display a broad range of biological effects, including, reducing toxicity and enhancing the efficacy of chemo/radio-therapy and regulating tumor microenvironment and cancer cells when applied to the treatment of tumors.,
Xi huang pill (XH), also termed Xi huang Wan, is a CAM currently used for tumor treatment. We previously reported that XH and its ingredients could inhibit the growth of tumor cells and cancer stem cells, prevent tumor invasion and angiogenesis, and regulate the tumor microenvironment. However, the clinical effects of XH on tumor treatment have yet to be quantitatively evaluated. Thus, the present meta-analysis was conducted to evaluate the effects of XH combined with chemotherapy for the treatment of patients with tumors. The present study was performed in accordance with the PRISMA statement [Supplementary File 1] and will endeavor to provide further clinical evidence of the effects of XH.
Report from Journal of Cancer Research
Xi huang pills enhance the tumor treatment efficacy when combined with chemotherapy:
A meta-analysis and systematic review.
See full report and download PDF Version
Website www.china-herbal.co.uk - Email firstname.lastname@example.org
Copyright (C) 2010 / 2019 Global Health Foods. All rights reserved
Chinese Herbal Medicine, Chinese Medicine, Herbal Medicine
Objective: To evaluate Xi huang pill combined with chemotherapy for tumor treatment in a meta-analysis.
Materials and Methods: We searched PubMed, Excerpta Medica Database, the Cochrane Library, the China National Knowledge Infrastructure, and the Weipu database and Wanfang Databases for eligible studies. We manually searched for printed journals and relevant textbooks. Statistical analyses were performed with Review Manager 5.3 (Cochrane Community, London, United Kingdom) and STATA 12.0 software packages.
Results: Fifteen studies were included. Xi huang pill combined with chemotherapy could enhance response (risk ratio [RR] =1.35, 95% confidence interval [95% CI]: 1.14?1.60, P < 0.0004), improve disease control (rr = 1.13, 95% ci: 1.05?1.21, p = 0.0006), prolong overall survival (hazard ratio = 0.80, 95% ci: 0.08?0.98, p = 0.03), improve patient quality of life (rr = 1.35, 95% ci: 1.10?1.67, p < 0.004), reduce 2?4° leukocyte (white blood cell) and platelet count due to chemotherapy (pooled rr = 0.42, 95% ci = 0.30?0.60, pooled rr = 0.42, 95% ci = 0.25?0.72, respectively).
Conclusion: Xi huang pill combined with chemotherapy can enhance the short-term efficacy and overall survival, alleviate treatment-induced side effects, and serve as a suitable regimen for the treatment of patients with tumors.